TruBridge (STU:PS1) Research & Development: €27.3 Mil (TTM As of Mar. 2026)


STU:PS1 TruBridge Inc STU:PS1
74 GF Score
Price €22.80
GF Value €16.70
! 6 Warning Signs
View Full Analysis

What is TruBridge Research & Development?

TruBridge STU:PS1 74 Research & Development is €27.3 Mil as of Mar. 2026. GuruFocus rates STU:PS1 with a GF Score™ of 74/100 and a GF Value™ of €16.70. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. TruBridge's Research & Development for the three months ended in Mar. 2026 was €6.4 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €27.3 Mil.

TruBridge  (STU:PS1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

TruBridge Research & Development Related Terms

TruBridge Research & Development Historical Data

* Premium members only.

The historical data trend for TruBridge's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TruBridge Research & Development Chart

TruBridge Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.04 30.11 35.60 33.85 27.80

TruBridge Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.63 7.03 6.96 6.86 6.44
STU:PS1
74GF Score
TruBridge Inc STU:PS1
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TruBridge Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €27.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €27.3 Mil mean?
TruBridge (STU:PS1) has a Research & Development of €27.3 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on TruBridge and its competitors.
Is TruBridge's Research & Development too high?
TruBridge's current Research & Development is €27.3 Mil. Overall, TruBridge has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does TruBridge's Research & Development compare to SOPH and CTEV?
TruBridge's Research & Development of €27.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on TruBridge and its competitors. TruBridge's current Research & Development is €27.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TruBridge stock overvalued right now?
TruBridge (STU:PS1) has a current Research & Development of €27.3 Mil. The stock's GF Value™ is €16.70, compared to a current price of €22.80 — trading 36.5% above its estimated fair value. The current Research & Development is €27.3 Mil. TruBridge's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For TruBridge (STU:PS1), the current Research & Development is €27.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TruBridge (STU:PS1) Overvalued in 2026?

Based on GuruFocus' analysis, TruBridge stock appears to be overvalued. The current stock price of €22.80 is trading 36.5% above its estimated GF Value™ of €16.70.

Key valuation signals for STU:PS1:

  • Research & Development: €27.3 Mil
  • GF Value™: €16.70 vs. price of €22.80 (36.5% above fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the STU:PS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TruBridge Business Description

Other Exchanges TBRG:USAPS1:Germany
Address 54 Street Emanuel Street, Mobile, AL, USA, 36602
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The Company operates its business in two operating segments, which are: Financial Health and Patient Care. The Financial Health segment generating key revenue focuses on providing business management, consulting, and managed IT services, along with a complete RCM solution for all care settings, regardless of their primary healthcare information solutions providers. The Patient Care segment provides comprehensive acute care EHR solutions and related services for community hospitals and their physician clinics.
74GF Score

Get the complete analysis for STU:PS1

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.80
Price
€16.70
GF Value